BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AXIS Clinicals Announces Dr. Yati Chugh as CEO


1/31/2013 10:56:48 AM

Hyderabad, Jan. 15, 2013: AXIS Clinicals Group, a leading global Clinical Research Organization (CRO) announces the appointment of Dr. Yati Chugh as the Chief Executive Officer of AXIS Clinicals Limited. Dr. Chugh assumes the responsibility for overall activities of AXIS Clinicals Group companies with presence in India, Thailand and Mexico. Under his able leadership and guidance, AXIS Clinicals team will ensure that services are offered to partners with dedication, commitment, quality and performance.

Dr. Chugh brings over two decades of experience in conducting pre-clinical, Bioequivalence / Bioavailability (BA/BE) studies and clinical research. He has extensive experience in areas of CNS, CVS, drug metabolism / pharmacokinetics and clinical pharmacology.

“As AXIS Clinicals is one of the leading CRO’s of the country,that provides clinical studies on both male and female healthy patient population in virtually all therapeutic areas, I am looking forward to our continued leadership in delivering the AXIS Advantage of timely deliveries, accuracy and quality in accordance to global standards to our clients & partners,” Dr. Yati Chugh, CEO said. “Our fundamental focus is to provide our customers a complete clinical research portfolio under one roof that will help them achieve the competitive advantage needed in staying ahead,” he added.

Dr. Chugh holds a doctorate degree from PGIMER, Chandigarh and has published about 45 scientific papers in reputed national and international peer-reviewed journals. He has completed his Master’s and Ph.D in pharmacology from PGIMER, Chandigarh and graduated in B.Pharm from Department of Pharmaceutical Sciences, Punjab University, Chandigarh. He has about 25 patents to his credit and is a member of all the major international bodies of pharmacology and is a reviewer in major Journals of Pharmacology.

Prior to joining AXIS Clinicals, Dr. Chugh was heading Lotus Labs as Managing Director. He has been associated with several reputed biopharmaceutical companies like Wockhardt, Intas Pharmaceuticals, Torrent Pharmaceuticals Limited for over two decades.

About AXIS Clinicals

AXIS Clinicals Limited, one of India’s leading CRO is committed to serving the biopharmaceutical industry by leveraging two powerful trends impacting the world of Clinical Research – globalisation and full spectrum offering. Established in September 2004, the company has completed over 1500 clinical studies, 300 ANDA studies and received 50 product approvals from regulatory agencies. The company facilities have been accredited by DCGI (Drugs Controller General, India), NABL (National Accreditation Board for Testing and Calibration Laboratories – ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA and France AFSSAPS and conforms to ICH and CDSCO-GCP & GLP Guidelines. For further details, please visit – www.axisclinicals.com

For further details, contact:

Shankar Chelluri, S Paradigm Consultants, P: +91.99490.93501



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES